IO Biotech's cancer vaccine Cylembio failed to hit the mark in a phase 3 melanoma trial – but the company hopes to file for approval regardless. The company said that the study "narrowly missed" the ...
Anneliese Michel’s name still gets tossed around like a campfire prop: say it in a low voice, mention “real exorcism,” and watch the room lean in. That reflex is understandable—the details are eerie, ...
This project uses Quarkus, the Supersonic Subatomic Java Framework. If you want to learn more about Quarkus, please visit its website: https://quarkus.io/. The ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results